|Articles|April 7, 2014
UBC Named Preferred Oncology Research Partner
United BioSource Corp. has been named the preferred oncology research partner by RainTree Oncology Services Corp
Advertisement
United BioSource Corp. (UBC) has been named the preferred oncology research partner by RainTree Oncology Services Corp., a community oncology alliance. The alliance seeks to standardize research processes within the the RainTree community oncology setting, UBC will have access to patient data and will partner to administer prospective and retrospective observation studies, which will provide information about the safety and efficacy of medicine in daily clinical use. UBC is a subsidiary of Express Scripts.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
3
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
4
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
5